Ankyra Therapeutics
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Ankyra Therapeutics
Scrip
• By Joseph Haas
Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem
Scrip
• By Mandy Jackson
The Alliance for Regenerative Medicine reported on 22 November that cell and gene therapy companies have raised enough money already in 2021 to break the record set in 2020. Venture capital financings